CBDIA Opens LATAM Chapter with Impressive Board

The CBD Industry Association (CBDIA) continues to expand and impress with its Latin American Advisory Board poised to make a strong and effective impact within the industry at large as it quickly grows its reach around the world. CBDIA Executive Director, Graciela Moreno expressed her excitement for, “the incredible group of leaders in LATAM that will be joining us and uniting to further the cannabinoid industry. We are able to join together and further the CBDIA’s mission on a global scale.”

Felipe Varas will hold the role of Regional Director & Chair brining a solid background of experience within the industry as a co-founder of Canopy Growth Latin America Division as well as being a founder and CSO of Diamond Hemp Chile. This background and direct experience is sure to be put into use as Varas leads CBDIA LATAM into the future.

The rest of the board is complimented by Regional Advisors Ethan Eastwood, an agribusiness juggernaut in his own right, Facundo Julián Alvarez, a physician and Director of International Relations for CANNAMERICA, and Sergio Sánchez Bustos, MD, who serves as Director for the NGO Latinoamerica Reforma.

The vast and varied skills and capabilities afforded by such a qualified and eclectic board are sure to drive the CBDIA LATAM chapter to reach new heights in the industry while spreading knowledge and understanding that will inevitably lead to continued progress. With such a diverse skillset ranging from cannabinoid research to education to policy reform, this board is more than capable of shaping the direction of the industry in Latin America and beyond.

“LATAM is one of the fastest growing cannabis and hemp markets,” says Moreno, and the expansion of the CBDIA here “will be an incredible opportunity for companies from the States to partner with and expand into Latin America. LATAM is ripe for cultivation and could possibly become the largest and biggest hemp producer.”

These are exciting times for the hemp and cannabis industries and the success and progression seen in the US is overdue to expand outside any borders. The opening of CBDIA LATAM represents the beginning of many years of continued growth within the region as well as an impressive evolution led by the capable minds, vast experience, and dedication to advancement that the new board members bring to the table.

Image credit: https://www.123rf.com/clipart-vector/latin_america.html?sti=m0d7kzns40xo36x3gz|

CBDIA Appoints Strategic Communications Veteran Jordan Isenstadt to Board of Advisors

Marino Senior Vice President help lead strategic communications efforts for CBDIA

NEW YORK – July 7, 2020 – The CBD & Cannabinoid Industry Association (CBDIA) today announced the appointment of Marino Senior Vice President Jordan Isenstadt to the association’s board of advisors. Marino is a full-service communications firm delivering data-driven, fully integrated strategies focused on changing perceptions, amplifying impressions and fostering high-level relationships to build brands. The firm will be the exclusive public relations partner for CBDIA.

“We are proud to add Jordan Isenstadt, a longtime communications strategist in the cannabis industry, to our growing board of advisors,” said CBDIA Executive Director Graciela Moreno. “Jordan and I share the same vision of positively altering and correcting the public’s perception of CBD and other cannabinoids. We know that this can only be achieved through communication, strong research and education. Jordan will be an asset in helping us to achieve these goals.”

As a senior vice president at Marino, a leading strategic communications firm with offices in New York City and Los Angeles, Isenstadt leads the agency’s cannabis practice, among other verticals including higher education and energy. Over the last four years, Marino has successfully built and expanded a cannabis unit, working with clients including Curaleaf, True Terpenes, Jenny’s Baked At Home, Breeder’s Best, REVEL, Xtraction Services, and Potbotics. Earlier this year, the agency also founded and launched the Cannabis Media Lab, a start-up accelerator that provides socially responsible cannabis entrepreneurs with specialized media-focused skills and resources.

“I look forward to solidifying CBDIA as the authoritative thought leader on the future of CBD and other cannabinoids in my new role on the board of advisors,” said Isenstadt. “As a strong supporter of CBD, cannabinoids and cannabis, I am committed to continue advocating for the plant while contributing to the Association’s mission to elevate awareness.”

Prior to joining Marino, Isenstadt was global chief communications officer at Australian-based education provider, Ducere Global Business School. Previously, he served as deputy director of the Association for a Better New York, a New York City based non-profit. Earlier in his early career, Isenstadt spent time in various political communications roles in the New York State Governor’s Office and for New York State Senator Liz Krueger, among others.

About the CBD Industry Association:

The CBD Industry Association (CBDIA) captures the ceaseless development and explosive growth as the cannabinoid industry’s leading trade association. They deliver essential resources so that those involved in the industry can share real-world knowledge and experiences. CBDIA nurtures and advances enduring success and awareness – no matter where you are in the industry. CBDIA was founded by Celeste Miranda who leads Celeste Miranda & Associates, as well as MACE Media Group (MMG). MMG is a leader in the cannabinoid publishing and event space, publishing Terpenes & Testing Magazine, Extraction Magazine, CBD Health & Wellness,

TOPICAL Magazine and the Journal of Cannabinoid Medicine, and producing The CBD Expo Tour, CannaFarm Con and CONCENTRATION Conferences. For more information, visit the CBDIA website.

CBDIA Board Member Jim DeMesa, MD, MBA Featured in Latest Issue of CBD Health & Wellness Magazine

Pismo Beach, CA, June 1, 2020 – Today MACE Media Group published the latest issue of CBD Health & Wellness Magazine with a cover and feature article devoted to Cannabinoid Industry Association (CBDIA) Board Member Jim DeMesa, MD, MBA, Emerald Health Pharmaceuticals (EHP) President and CEO, and his colleagues.

The issue highlights the development of a novel cannabinoid compound, EHP-101, currently in testing as a treatment for multiple sclerosis (MS). Dr. DeMesa discussed how this new cannabinoid-derived therapy could significantly impact disease course and potentially achieve the “Holy Grail” of MS by reversing the neural damage caused by the disease.

MACE Media Group CEO Celeste Miranda, who lives with MS, introduces the feature article with a heartfelt note about her experience and how cannabinoids have been instrumental in managing her symptoms. Miranda’s commitment to the cannabinoid industry is a personal one and she is honored to share this research.

“CBDIA exists to bring together leaders in the cannabinoid industry to foster collaboration and growth. Through our publications, we seek to highlight the latest findings from industry leaders and medical professionals and are thrilled to share the cutting-edge research of companies like EHP that are working hard to bring new cannabinoid-based therapies to patients,” noted Miranda.

In the article, Dr. DeMesa discusses years of diligent work led by Eduardo Muñoz, MD, PhD and Giovanni Appendino, PhD to modify and optimize cannabinoid molecules and make them better suited to target certain receptors and biologic pathways throughout the body which are targets for various diseases with unmet medical needs. EHP is currently advancing EHP-101 through clinical trials to assess its treatment potential for systemic sclerosis and MS, and is conducting preclinical work on a second molecule, EHP-102, focused on Parkinson’s disease and Huntington’s disease.

“It is an honor to have the opportunity to discuss our work at EHP with the CBDIA community,” said Dr. DeMesa. “Our approach to developing a new treatment paradigm for diseases like MS with unmet medical needs and no cures is based on the convergence of cannabinoids, biology, and science. Our initiation of Phase II is now underway with EHP-101, which is a novel, patented synthetic cannabidiol (CBD) derivative that has demonstrated significant, positive results in pre-clinical and Phase I studies.”

The CBD Health & Wellness team is grateful to Dr. DeMesa’s for sharing his insights with our readers.

About MACE Media Group

MACE Media Group publishes niche cannabis industry trade publications. Its first title, Terpenes and Testing Magazine, was the first industry trade publication devoted to cannabis science. Its newer publications, CBD Health & Wellness Magazine, Extraction Magazine, and TOPICAL Magazine, revolve around the growing CBD and cannabinoid industry to provide news on trending applications, medical research, and updates with laws and regulations.

MACE also produces many trade events that attract dozens of cannabis and mainstream media journalists. Currently, MACE Media Group is producing a tour of CBD expos bringing together thousands of industry influencers, forming the most comprehensive CBD event in the United States.

Find out more at MACE Media Group.

About CBDIA

CBDIA empowers professionals in the cannabinoid industry with education, advocacy, and community. We serve as the premier expert resource on trends, technologies, legalities, limitations, developments, and other issues that affect your business by nourishing a community of shared knowledge and resources to benefit everyone. CBDIA elevates awareness and expands knowledge and advocate for legal and regulatory environments that benefit our entire industry.

Find out more at CBDIA.

www.Cbdindustryassociation.org

info@cbdindustryassociation.org

PURCHASE Your Copy of CBD Health & Wellness Magazine HERE

The CBD Industry Association (CBDIA) Proudly Welcomes Priscilla P. Agoncillo as its new President of the Board of Advisors

Pismo Beach, CA, May 21, 2020 – The CBD Industry Association (CBDIA) proudly welcomes Priscilla P. Agoncillo as its new President of the Board of Advisors.

Priscilla P. Agoncillo brings a passion for advocacy and abundant experience that will benefit the association and industry at large. As a prominent business advisor serving the cannabinoid industry for over 15 years, Ms. Agoncillo has expertise in business strategy, branding, and business development with a thorough background in banking, private equity, sales and entertainment.

As a cannabinoid advocate, Priscilla has appeared countless times as a public speaker for patient rights, law reform, and cannabis business insight on various newspapers, television, radio programs, and industry conferences.

Ms. Agoncillo served as the Campaign Field Director of Proposition 19, the first initiative to tax and legalize cannabis for the state of California, helping pave the legal pathway for the most significant legal cannabis market in the world. Priscilla also served the California Hemp Association and Foundation advising, conducting R&D and developing some of the first large-scale commercial hemp farms in California. This familiarity and proficiency in cannabis and hemp politics adds serious significance to her role within the CBDIA.

Ms. Agoncillo is Co-Owner of OBL Biodynamic Farms, a multiple award-winning licensed cannabinoid breeding farm & Co-Founder of the Original Breeders League – an organization created to gather top-performing cannabinoid breeders from around the world to collaborate in comprehensive and commercially-driven cannabis and hemp breeding projects. These projects have helped to develop various international companies throughout Latin America, the Caribbean, Europe, California, USA.

Ms. Agoncillo currently serves as the Chief Business Officer for Mandara Pharma Inc., a Canadian/Colombian based cannabinoid pharmaceutical company and has helped form and direct a global business strategy spanning across North America, LATAM, Australia and Europe.

“We are very excited and ever thankful for Priscilla’s involvement with the CBDIA,” says the association’s founder, Celeste Miranda. “Her background in business strategy and politics will serve as a solid resource for our members and community. She will make a great leader for our rapidly expanding association.”

Graciela Moreno, Executive Director of the CBDIA adds, “Ms. Agoncillo has vast knowledge in many aspects of the cannabinoid industry and we couldn’t be happier to have her take the reigns as President of the Board. Her insight and expertise are sure to prove tremendously valuable and the intrigue of her international involvement is apparent as the industry develops around the globe.”

Ms. Priscilla Agoncillo intimately understands the needs and trends of the domestic and global cannabinoid industry. As President of the Board of CBDIA, her experience will help guide CBDIA members to establish their businesses successfully in emerging markets, navigate through continually evolving regulations and help members strategically prepare and position their businesses for success within the growing cannabinoid industry through education, advocacy and the CBDIA’s highly esteemed community of cannabinoid professionals.

The CBD Industry Association (CBDIA) Proudly Welcomes D.C. Lobbyist Romano Romani, Ph.D. as a Member of its Advisory Board

Pismo Beach, CA, April 16, 2020 – The CBD Industry Association (CBDIA) proudly welcomes Romano Romani, Ph.D. as a member of its advisory board. Romani will take the lead on representing the CBD Industry, through CBDIA, on “the hill” in D.C.

Romani brings with him decades of lobbying experience in the halls of congress alongside a passionate pursuit of progressing the future of the CBD industry. He has been instrumental in getting H.R.5587 in front of key policy makers at the highest level. This bill, now in line to be approved by the US Congress, is a significant step in amending the Federal Food, Drug, and Cosmetic Act to ease regulations on CBD and CBD containing substances.

The influence and clout that Romani directly brings to the CBDIA is evident through his current efforts to fundamentally change the Federal stance on hemp products alongside a decade spent as Legislative Director and Staff Director for two former Senators. He was previously a Professor of Political Science and holds a Ph.D. from The Johns Hopkins University as well. The many proficiencies he possesses are certain to have a direct impact on the CBDIA and his personal efforts may very well end up shaping the very substance of the CBD and cannabis industries moving forward.

“We are tremendously grateful to have Mr. Romani as a member of our Advisory Board,” remarked CBDIA Executive Director, Graciela Moreno. “His political and legislative experience is a welcome and much needed asset towards furthering our reach and influence at a level that can candidly change our industry for the better. He provides us with a working knowledge of how to lobby and promote our efforts into empowering the industry with education and advocacy.”

Romani is also personally intrigued by the hemp and CBD industries and sees great potential in the near future. “I am excited to contribute my knowledge and experience as part of the CBDIA while continuing efforts to change Federal positioning on the regulations surrounding hemp-derived products,” he states.

In the steadily progressing world of hemp and cannabis regulations, Romani adds substantial authority to expand the effectiveness of the CBDIA while promoting and pursuing key changes in the laws and regulations that will shape the scope of the industry.

About CBD Industry Association:
The Cannabinoid Industry Association (CBDIA) captures the ceaseless development and explosive growth of the CBD and Cannabis industry as the industry’s leading trade association. CBDIA empowers professionals in the cannabinoid industry with education, advocacy, and community. CBDIA nurtures and advances enduring success and awareness – no matter where you are in the industry.

Contact Information:

MACE Media Group

Celeste Miranda, CEO

805-530-2424

info@macemediagroup.com

CBD Expo EAST Breaks Records for the CBD Industry in Florida

The second stop of the CBD Expo Tour came to a conclusion in the afternoon hours on Saturday this past weekend.

DECEMBER 12, 2018  CBD Expo EAST broke records, welcoming over 4,000 visitors for the first time Florida visit. The crowd spread itself through the extensive schedule of over 40 education sessions featuring industry physicians, scientists and other speakers from around the world.

Totaling over 80 speakers participating in keynote presentations, panel discussions, interactive workshop, stage demonstrations and certification classes on a variety of topics relating CBD and its health benefits. The conference has seen a consistent increase of attendance numbers since it embarked on its tour with an opening stop in Anaheim, California, in September.

“It is incredible to see this event growing location over location,” MACE Media Group’s CEO, Celeste Miranda, said. “Not only have we expanded the event in terms of exhibit space, but we again reached a record high in the number of visitors who came to the event. This shows the ongoing importance of the business value that both buyers and suppliers in the global CBD industry find in this event.”

The event includes CBD Health & Wellness Magazine Awards, recognizing outstanding CBD Products. In the competition, a panel of industry experts in CBD products judged 40 finalists on their taste, originality, practicality, innovation, packaging, market potential and nutritional aspects.

The exhibitors were extremely pleased with the turnout. Gwen Garret, the Director of Marketing for CFH Ltd. said, “Thank you all so much for your hard work. It was very professional and so well organized. The show turned out beautifully and we are all very grateful! We appreciate all you have done to raise the caliber of the industry and elevate the conversation!”

CBD Coaching certifications were also given through the CBD Training Institute after more than 30 attendees completed the required hours of training and testing. “Our Dream Team of CBD Experts provided a deep domain of knowledge and the feedback from the coaches were excellent,” commented CBD Training Academy’s CEO, Rick Diamond.

The next stop on the CBD Expo Tour is Indianapolis, Indiana, on March 15-16. For more information go to cbdexpo.net.

Cannabinoid Medicine Studies Appoints New Executive Director

Pismo Beach, CA – March 26, 2020 – The Cannabinoid Medicine Studies has named Heidi Sewell Executive Director. Heidi previously served as the Executive Director of the CBD Industry Association and is stepping into this newly created position for the fastest growing education provider in the cannabinoid medicine space.

The Cannabinoid Medicine Studies program, whose curriculum is all physician created and physician or Ph.D. taught currently offers several certification programs within the industry including…

● Certified CBD Consultant
● Certified Flavonoid Specialist
● Certified Cannabinoid Blending Formulator
● A Day with MacKay: The Cannabinoid Extraction
● Certified Minor Phytocannabinoid Specialist
● Cannabinoid Sports Specialist
● Accredited Terpene Specialist
● Certified CBD Compliance Consultant
● Certified CBD Pain Management Consultant
● Certified Cannabinoid Senior Care Specialist
● Certified CBD Skincare Consultant

Heidi Sewell comes to the Cannabinoid Medicine Studies program from an impressive history in the industry and has been instrumental in launching the CBD Industry Association, which will endorse the certification courses. “I am very proud to be a part of the Cannabinoid Medicine Studies ,” said Heidi Sewell, Executive Director. “It is really all about the education of CBD professionals and how we are helping to shape the future of the cannabinoid industry.”

For more information on the Cannabinoid Medicine Studies,
visit their website at 
cannabinoidmedicinestudies.com

About the Cannabinoid Medicine Studies:
The Cannabinoid Medicine Studies are endorsed by the Cannabinoid Industry Association and offers certification courses that are overseen by our partnered physician and CMO, Adam Abodeely, (MD, MBA, FACS, FASCRS) to provide specialization and continuing education platforms for its members, cbd industry professionals and medical professionals.

CBD Industry Association Appoints New Executive Director While Current Director Takes Over Cannabinoid Medicine Studies Program

MARCH 31, 2020 – Pismo Beach, CA – The CBD Industry Association has named Graciela Moreno Executive Director. Graciela previously served as the Director of Member Engagement and is stepping into the position vacated by Heidi Sewell who has taken on Executive Director duties for the Cannabinoid Medicine Studies program.

“Heidi has been instrumental in the progression of CBDIA and we look forward to her doing the same for the CMS program. Gracie was a natural choice to take over Executive Director duties, since her work as the Director of Membership Engagement has been impressive. I look forward to the positive moves as we have a lot coming up”, said Celeste Miranda CBDIA Founder.

The Cannabinoid Industry Association (CBDIA) captures the ceaseless developments in the CBD and cannabinoid industry and its explosive growth as the leading trade association. CBDIA delivers essential resources so that those involved in the industry can share real-world knowledge and experiences. CBDIA nurtures and advances enduring success and awareness.

Moreno comes to CBDIA from a long history in the industry and has been instrumental in increasing retention in the association’s membership. “Being involved in the cannabis industry at this time is very exciting and being able to help the CBD industry grow through community is such a privilege”, Moreno added.

The CBD Industry Association is currently accepting new memberships and preferred partners. For more information, visit the website at cbdindustryassociation.org.

About CBD Industry Association:

The Cannabinoid Industry Association (CBDIA) captures the ceaseless development and explosive growth of the CBD and Cannabis industry as the industry’s leading trade association. CBDIA empowers professionals in the cannabinoid industry with education, advocacy, and community. CBDIA nurtures and advances enduring success and awareness – no matter where you are in the industry.

CBD Industry Association and the Cannabinoid Medicine Studies Partner with the CWCBExpo Events

Pismo Beach, CA – April 7, 2020 – Today the Cannabinoid Medicine Studies program and its primary endorser, the CBD Industry Association jointly announced that they will be partnering with the popular Cannabis World Congress & Business Expo (CWCBExpo) trade shows and conferences in Los Angeles, New York and Boston in 2020.

The Cannabinoid Medicine Studies program, whose curriculum is all physician created and physician or Ph.D. taught will be conducting their courses and subsequently issuing certifications, after testing. Courses will be conducted throughout the 2-3 days of the conferences. Certifications include Certified CBD Consultant, Certified Flavonoid Specialist, Certified Cannabinoid Blending Formulator, A Day with MacKay: The Cannabinoid Extraction, Certified Minor Phytocannabinoid Specialist, Cannabinoid Sports Specialist, Accredited Terpene Specialist, Certified CBD Compliance Consultant, Certified CBD Pain Management Consultant, Certified Cannabinoid Senior Care Specialist and Certified CBD Skincare Consultant.

“We are excited to have our instructor physicians in attendance and bring our certification courses to the CWCBExpo conferences,” said Heidi Sewell, Executive Director.

The Cannabinoid Industry Association (CBDIA) is the entity responsible for bringing these educational courses to CWCBExpo. As the largest endorser of the courses and the certifications, CBDIA will also be partnering with CWCBExpo, bringing an inaugural pavilion to the exhibit floor. The pavilion will showcase CBDIA members and their services. Attendees will also be able to discuss membership with senior CBDIA team members..

“Joining forces and partnering with CWCBExpo is such a great opportunity for us to continue our mission of educating, informing, supporting, and advancing the cannabis industry as a whole,” said Graciela Moreno, Executive Director

“We are looking forward to having the CBDIA Pavilions and the  physician created Cannabinoid Medicine Studies and certification programs at our 2020 events,” said Greg Marco, President of CWCBExpo.

CWCBExpo conferences will be held in Los Angeles, September 16-17 ; New York, October 1-3; and Boston, October 21-22.

About CBD Industry Association:
The Cannabinoid Industry Association (CBDIA) captures the ceaseless development and explosive growth of the CBD and Cannabis industry as the industry’s leading trade association. CBDIA empowers professionals in the cannabinoid industry with education, advocacy, and community. CBDIA nurtures and advances enduring success and awareness – no matter where you are in the industry.

About Cannabinoid Medicine Studies:
The Cannabinoid Medicine Studies are endorsed by the Cannabinoid Industry Association and offers certification courses that are overseen by our partnered physician and CMO, Adam Abodeely, (MD, MBA, FACS, FASCRS) to provide specialization and continuing education platforms for its members, CBD industry and medical professionals.

As the CBD industry continues to grow, there are many evolving complexities that require strategic know-how and the most up-to-date knowledge on the nuisances of the industry to get ahead. Our courses offer the key essentials to prepare the CBD industry to take on these demands to be able to help their clients and patients reach their goals.

About Cannabis World Congress & Business Expositions (CWCBExpo):

CWCBExpos (www.cwcbexpo.com) are the premier business-to-business events for the legalized cannabis industry and are held 3 times per year in the largest business, financial, and media markets—New York City, Los Angeles and Boston. The CWCBExpo Cannabis Week will bring the industry together for continued networking and community-building. Connect on Twitter, Facebook, Instagram, and LinkedIn: @cwcbexpo.

The CBD Industry Association (CBDIA) has named Graciela Moreno the Director of Member Engagement.

Pismo Beach, CA, October 17, 2019 – The CBD Industry Association (CBDIA) has named Graciela Moreno the Director of Member Engagement.

 

Moreno, who has been in the cannabinoid space since 2014 has played a signifiant role in furthering the industry as President of Med-Cannabis Pharma and and then Editor-in-Chief of CannaInvestor Magazine. She currently owns La Dulce Vida CBD.

 

“We are extremely grateful for Gracie’s creativity, drive and passion,” commented CBDIA Founder, Celeste Miranda. “Her member facing experience and ambition, coupled with her detailed knowledge and inner workings of our industry, are a winning combination for tackling so many of the engagement activities she will spearhead. She is truly a person who is committed to finding new and creative ways to get members more involved in the association, and I believe her tenacity alone will help us reach new levels of success.”

 

As Vice President of Member Engagement, Moreno will be tasked with establishing new levels of member involvement, both large and small, while continuing to work alongside each of the departments within the association. As a key member of the operations team, Graciela will work to expand the various areas of engagement ranging from business offered services and programs to a plethora of arranged discount membership offerings and ambassador programs.

 

“I’m excited to begin this journey to further our industry through the amazing things that CBDIA is doing. We will continue to be trailblazers in the development of all standards, while maintaining an active membership engagement,” said Moreno.

 

“Everything is moving so fast in this space. While we are busy with new memberships and our certificated education programs, Graciela will fill the gap of ensuring our current membership is well serviced with plentiful benefits,” said Heidi Sewell, CBDIA Executive Director.

 

 

About the CBD Industry Association:

The CBD Industry Association (CBDIA) captures the ceaseless development and explosive growth as the cannabinoid industry’s leading trade association. They deliver essential resources so that those involved in the industry can share real-world knowledge and experiences. CBDIA nurtures and advances enduring success and awareness – no matter where you are in the industry.

 

CBDIA was founded by Celeste Miranda who leads Celeste Miranda & Associates as well as MACE Media Group (MMG). MMG is a leader in the cannabinoid publishing and event space, publishing Terpenes & Testing Magazine, Extraction Magazine, CBD Health & Wellness,
TOPICAL Magazine and the Journal of Cannabinoid Medicine. The produce The CBD Expo Tour, CannaFarm Con and CONCENTRATION Conferences. Please refer to the website to see members of the Board of Advisors, chaired by Michael Brubeck of Centuria.